The DOI matches its Crossref record; 55 of the 56 references it cites were found in a registry or an index.
Why have clinical trials in sepsis failed?
Abstract
The systemic inflammatory response is biologically complex, redundant, and activated by both infectious and noninfectious triggers. Its manipulation can cause both benefit and harm. More than 100 randomized clinical trials have tested the hypothesis that modulating the septic response to infection can improve survival. With one short-lived exception, none of these has resulted in new treatments. The current challenge for sepsis research lies in a failure of concept and reluctance to abandon a demonstrably ineffectual research model. Future success will necessitate large studies of clinical and biochemical epidemiology to understand the course of illness, better integration of basic and clinical science, and the creation of stratification systems to target treatment towards those who are most likely to benefit.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The underlying molecular mechanisms behind pathological capillary leakage remain incompletely understood, hindering the development of targeted therapies aimed at vascular stabilization (3).”
From Targeting β1-integrin inhibits vascular leakage in endotoxemia (2018) · cites this paper as [3]
In the citing paper
“Increased capillary leakage leading to hypovolemic shock and multiorgan failure is a key event in the pathobiology of several difficult-to-treat conditions, such as sepsis (2, 3, 6).”
From Targeting β1-integrin inhibits vascular leakage in endotoxemia (2018) · cites this paper as [3]
In the citing paper
“Over the last 40 years, more than 100 clinical trials of would‐be sepsis drugs aimed at modulating host immune responses to infection have failed.”
From On race, human variation, and who gets and dies of sepsis (2022) · cites this paper as Marshall, 2014
Citations
Cites
Bone, R. C., BALK, R. A., Cerra, F. B., Dellinger, R. P., Fein, A. M., Knaus, W. A., Schein, R. M. H., & Sibbald, W. J. (1992) · CHEST Journal · doi:10.1378/chest.101.6.1644 · Cited by 13,317
Early goal-directed therapy in the treatment of severe sepsis and septic shock
Rivers, E., Nguyen, B., Havstad, S., Ressler, J., Muzzin, A., Knoblich, B., Peterson, E., & Tomlanovich, M. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010307 · Cited by 10,743
Angus, D. C., Linde-Zwirble, W. T., Lidicker, J., Clermont, G., Carcillo, J., & Pinsky, M. R. (2001) · Critical Care Medicine · doi:10.1097/00003246-200107000-00002 · Cited by 8,503
Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene
Poltorak, A., He, X., Smirnova, I., Liu, M.-Y., Huffel, C. V., Du, X., Birdwell, D., Alejos, E., Silva, M., Galanos, C., et al. (1998) · Science · doi:10.1126/science.282.5396.2085 · Cited by 7,631
Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis
Bernard, G. R., Vincent, J., Laterre, P., LaRosa, S. P., Dhainaut, J.-F., Lopez-Rodriguez, A., Steingrub, J. S., Garber, G. E., Helterbrand, J. D., Ely, E. W., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103083441001 · Cited by 6,124
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference
Levy, M. M., Fink, M. P., Marshall, J. C., Abraham, E. H., Angus, D. C., Cook, D., Cohen, J., Opal, S. M., Vincent, J., & Ramsay, G. (2003) · Critical Care Medicine · doi:10.1097/01.ccm.0000050454.01978.3b · Cited by 5,976
Self-citationIntensive versus Conventional Glucose Control in Critically Ill Patients
(2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810625 · Cited by 5,119
Genomic responses in mouse models poorly mimic human inflammatory diseases
Seok, J., Warren, H. S., Cuenca, A. G., Mindrinos, M. N., Baker, H. V., Xu, W., Richards, D. R., McDonald-Smith, G. P., Gao, H., Hennessy, L., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1222878110 · Cited by 3,005
Functional Disability 5 Years after Acute Respiratory Distress Syndrome
Herridge, M. S., Tansey, C. M., Matte, A. L., TOMLINSON, G. A., Diaz-Granados, N., Cooper, A., Guest, C. B., Mazer, C. D., Mehta, S., Stewart, T. E., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1011802 · Cited by 2,892
Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia
Tracey, K. J., Fong, Y., Hesse, D. G., Manogue, K. R., Lee, A. T., Kuo, G. C., Lowry, S. F., & Cerami, A. (1987) · Nature · doi:10.1038/330662a0 · Cited by 2,448
Flagged first, then by citations
1 of the 56 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Centers for Disease Control and Prevention, 1999, Achievements in public health, 1900–1999, MMWR, 48, 621
Cited by
Sorted by citations
Items 401–500 of 810
Ji, A., Trumbauer, A. C., Noffsinger, V. P., Meredith, L. W., Dong, B. E., Wang, Q., Guo, L., Li, X., de Beer, F. C., Webb, N. R., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242417501 · Cited by 12
Lindsell, C. J., McGlothlin, A. E., Nwosu, S., Rice, T. W., Hall, A. J., Bernard, G. R., Busse, L. W., Ely, E. W., Fowler, A. A., Gaieski, D. F., et al. (2019) · Trials · doi:10.1186/s13063-019-3775-8 · Cited by 12
Dynamic LTR retrotransposon transcriptome landscape in septic shock patients
MIPrea Study Group, Mommert, M., REALISM Study Group, Tabone, O., Guichard, A., Oriol, G., Cerrato, E., Denizot, M., Cheynet, V., Pachot, A., et al. (2020) · Critical Care · doi:10.1186/s13054-020-2788-8 · Cited by 13
Treatment of Pneumococcal Infection by Using Engineered Human C-Reactive Protein in a Mouse Model
Ngwa, D. N., Singh, S. K., Gang, T. B., & Agrawal, A. C. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.586669 · Cited by 12
Personalised immunotherapy in sepsis: a scoping review protocol
Slim, M. A., van Mourik, N., Dionne, J. C., Oczkowski, S. J. W., Netea, M. G., Pickkers, P., Giamarellos‐Bourboulis, E. J., Müller, M. C. A., van der Poll, T., Wiersinga, W. J., et al. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-060411 · Cited by 12
Chasing the Ghost: Hyperinflammation Does Not Cause Sepsis
Shapiro, L., Scherger, S. J., Franco‐Paredes, C., Gharamti, A. A., Fraulino, D., & Henao‐Martínez, A. F. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.910516 · Cited by 12
Nugent, W. H., Carr, D. A., Friedman, J. M., & Song, B. K. (2023) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2022.2164584 · Cited by 13
Sepsis: the need for tolerance not complacency
Velho, T. R., Santos, I., Póvoa, P. M. S. R., & Moita, L. F. (2016) · Swiss Medical Weekly · doi:10.4414/smw.2016.14276 · Cited by 12
Target Identification Using Chemical Probes.
Moustakim, M., Felce, S., Zaarour, N., Farnie, G., McCann, F., & Brennan, P. (2018) · Methods in Enzymology · doi:10.1016/bs.mie.2018.09.013 · Cited by 9
The pituitary gland prevents shock-associated death by controlling multiple inflammatory mediators
Sharma, A., Steven, S., & Bosmann, M. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.12.101 · Cited by 12
Staging and Personalized Intervention for Infection and Sepsis
Beckmann, N., Salyer, C. E., Crisologo, P. A., Nomellini, V., & Caldwell, C. C. (2020) · Surgical Infections · doi:10.1089/sur.2019.363 · Cited by 11
50 Years of Sepsis Investigation/Enlightenment Among Adults—The Long and Winding Road
Dellinger, R. P., Levy, M. M., Schorr, C., & Townsend, S. R. (2021) · Critical Care Medicine · doi:10.1097/ccm.0000000000005203 · Cited by 12
Cell-Derived Nanoparticles are Endogenous Modulators of Sepsis With Therapeutic Potential
Kunz, N., Xia, B. T., Kalies, K., Klinger, M. H. F., Gemoll, T., Habermann, J. K., Whitacre, B. E., Seitz, A. P., Kalies, K., & Caldwell, C. C. (2017) · Shock · doi:10.1097/shk.0000000000000855 · Cited by 12
How could we enhance translation of sepsis immunology to inform immunomodulation trials in sepsis?
Shankar‐Hari, M. (2017) · Critical Care · doi:10.1186/s13054-017-1715-0 · Cited by 12
Poole, A. P., Chaba, A., Bellomo, R., Bailey, M., Deane, A. M., Delaney, A. P., Eastwood, G. M., Haines, K. J., Hammond, N. E., Hensman, T., et al. (2025) · Intensive Care Medicine · doi:10.1007/s00134-025-08162-y · Cited by 15
The age of animal experiments is waning. Where will science go next?
Kwon, D. (2026) · Nature · doi:10.1038/d41586-026-00563-3 · Cited by 11
The immune landscape of sepsis and using immune clusters for identifying sepsis endotypes
Tang, G., Luo, Y., Song, H., Liu, W., Huang, Y., Wang, X., Zou, S., Sun, Z., Hou, H., & Wang, F. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1287415 · Cited by 11
Rodrigues, P. D. S., Picco, N., Morgan, B. P., & Ghazal, P. (2020) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2021.1851186 · Cited by 11
Development and validation of a nomogram for predicting the prognosis in cancer patients with sepsis
Yang, Y., Dong, J., Yang, L., Chen, R.-X., Tian, X., Wang, H., & Hao, C. (2022) · Cancer Medicine · doi:10.1002/cam4.4618 · Cited by 11
Liu, Y., Luo, T., Li, H., Zhao, X., Zhou, M., & Cheng, M.-L. (2022) · PubMed Central · Cited by 11
Jang, S.-Y., Kim, S., Song, H.-A., Kim, H., Chung, K., Lee, J. K., & Lee, K. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.111083 · Cited by 11
Protective role of thymoquinone in sepsis‑induced liver injury in BALB/c mice
Wang, F., Lei, X., Zhao, Y., Yu, Q., Li, Q., Zhao, H., & Pei, Z. (2019) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2019.7779 · Cited by 11
Multi-Biomarker Prediction Models for Multiple Infection Episodes Following Blunt Trauma
Tsurumi, A., Flaherty, P., Que, Y., Ryan, C. M., Mendoza, A. E., Almpani, M., Bandyopadhaya, A., Ogura, A., Dhole, Y. V., Goodfield, L. F., et al. (2020) · iScience · doi:10.1016/j.isci.2020.101659 · Cited by 11
Eichhorn, T., Linsberger, I., Lauková, L., Tripisciano, C., Fendl, B., Weiss, R., König, F., Valicek, G., Miestinger, G., Hörmann, C., et al. (2021) · Mediators of Inflammation · doi:10.1155/2021/8395048 · Cited by 11
Liu, F., Aulin, L. B. S., Kossen, S. S. A., Cathalina, J., Bremmer, M., Foks, A. C., van der Graaf, P. H., Moerland, M., & van Hasselt, J. G. C. (2022) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1007/s10928-022-09828-6 · Cited by 11
Protective Effect of Inflammasome Activation by Hydrogen Peroxide in a Mouse Model of Septic Shock
Huet, O., Pickering, R. J., Tikellis, C., Latouche, C., Long, F., Kingwell, B. A., Dickinson, B. C., Chang, C. J., Masters, S. L., Mackay, F., et al. (2016) · Critical Care Medicine · doi:10.1097/ccm.0000000000002070 · Cited by 11
An international observational study validating gene-expression sepsis immune subgroups
Antcliffe, D. B., Peronnet, E., Pène, F., Strålin, K., Brealey, D. A., Blein, S., Cleaver, R., Cronhjort, M., Diehl, J., Voiriot, G., et al. (2025) · Critical Care · doi:10.1186/s13054-025-05319-5 · Cited by 10
Value of animal sepsis research in navigating the translational labyrinth
Wang, H., Ayala, A., Aziz, M., Billiar, T. R., Deutschman, C. S., Jeyaseelan, S., Tang, D., & Wang, P. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1593342 · Cited by 10
Leveraging Transcriptomics to Disentangle Sepsis Heterogeneity
Wong, H. R., & Marshall, J. C. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201701-0143ed · Cited by 10
Self-citationCARDIOMYOCYTE REPROGRAMMING IN ANIMAL MODELS OF SEPTIC SHOCK
Hobai, I. A. (2022) · Shock · doi:10.1097/shk.0000000000002024 · Cited by 10
Namas, R. A., & Yoram Vodovotz, B. (2016) · Annals of Translational Medicine · doi:10.21037/atm.2016.11.72 · Cited by 10
Lelubre, C., Medfai, H., Akl, I., Leentjens, J., Kox, M., Pickkers, P., Rousseau, A., Biston, P., Piagnerelli, M., Vanhaeverbeek, M., et al. (2017) · Journal of Leukocyte Biology · doi:10.1189/jlb.5a0516-240r · Cited by 10
Liu, J., Li, G., Chen, C., Chen, D., & Zhou, Q. (2017) · PLoS ONE · doi:10.1371/journal.pone.0188604 · Cited by 10
Early-phase Innate Immune Suppression in Murine Severe Sepsis Is Restored with Systemic Interferon-β
Kusakabe, Y., Uchida, K., Yamamura, Y., Hiruma, T., Totsu, T., Tamai, Y., Tsuyuzaki, H., Hasegawa, K., Chang, K., & Yamada, Y. (2018) · Anesthesiology · doi:10.1097/aln.0000000000002185 · Cited by 10
Chen, L., Kraft, B. D., Roggli, V. L., Healy, Z. R., Woods, C. W., Tsalik, E. L., Ginsburg, G. S., Murdoch, D. M., Suliman, H. B., Piantadosi, C. A., et al. (2021) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00337.2020 · Cited by 10
Role of HSPGs in Systemic Bacterial Infections
Aquino, R. S., Hayashida, K., Hayashida, A., & Park, P. W. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1398-6_46 · Cited by 10
Ahn, D. S., & Prince, A. S. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiw405 · Cited by 10
Gebremariam, T., Zhang, L., Alkhazraji, S., Gu, Y., Youssef, E. G., Tong, Z., Kish-Trier, E., Bajji, A. C., de Araujo, C. V., Rich, B. E., et al. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00303-20 · Cited by 10
He, Y., Chen, X., Zhong, J., Lin, C., Situ, J., Liu, B., Yan, Y., Gui, S., Mao, C., & Xing, S. (2025) · Life Sciences · doi:10.1016/j.lfs.2025.123744 · Cited by 9
Immune Dysregulation in Sepsis. A Narrative Review for the Clinicians
Valsamaki, A., Vazgiourakis, V., Mantzarlis, K. D., Manoulakas, E., & Makris, D. A. (2025) · Biomedicines · doi:10.3390/biomedicines13102386 · Cited by 15
Epigenetics As The Driving Force In Long-Term Immunosuppression
Giménez, J. L. G., & Carbonell, N. (2016) · Journal of Clinical Epigenetics · doi:10.21767/2472-1158.100017 · Cited by 9
Tracking of GFP-labeled unrestricted somatic stem cells transplanted in the sepsis mouse model
Zarei‐Behjani, Z., Soleimani, M., Atashi, A., Ebrahimi‐Barough, S., Ai, J., & Hamidieh, A. A. (2019) · Tissue and Cell · doi:10.1016/j.tice.2019.07.009 · Cited by 9
Keij, F. M., Koch, B. E. V., Vigario, F. L., Simons, S. H. P., van Hasselt, J. G. C., Taal, H. R., Knibbe, C. A. J., Spaink, H. P., Reiss, I. K. M., & Krekels, E. H. J. (2021) · Journal of Clinical and Translational Science · doi:10.1017/cts.2021.803 · Cited by 11
On race, human variation, and who gets and dies of sepsis
Brinkworth, J. F., & Shaw, J. G. (2022) · American Journal of Biological Anthropology · doi:10.1002/ajpa.24527 · Cited by 9
Sorrentino, J. T., Golden, G. J., Morris, C., Painter, C. D., Nizet, V., Campos, A. R., Smith, J. W., Karlsson, C. A. Q., Malmström, J. A., Lewis, N. E., et al. (2022) · mSystems · doi:10.1128/msystems.00395-22 · Cited by 9
Truong, N., Cottingham, A. L., Dharmaraj, S., Shaw, J. R., Lasola, J. J., Goodis, C. C., Fletcher, S., & Pearson, R. M. (2023) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10611 · Cited by 9
Characterising Pre-pubertal Resistance to Death from Endotoxemia
Joachim, R. B., Suber, F., & Kobzik, L. (2017) · Scientific Reports · doi:10.1038/s41598-017-16743-1 · Cited by 9
New biomarkers for respiratory infections
Póvoa, P. M. S. R., Coelho, L., & Bos, L. D. J. (2020) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000669 · Cited by 9
Webber, R. J., Sweet, R. M., & Webber, D. S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222413371 · Cited by 9
MECHANISMS OF CARDIAC DYSFUNCTION IN SEPSIS
Hobai, I. A. (2022) · Shock · doi:10.1097/shk.0000000000001997 · Cited by 9
Gopinathan, U., Øvstebø, R., Brusletto, B. S., Olstad, O. K., Kierulf, P., Brandtzaeg, P., & Berg, J. P. (2017) · BMC Immunology · doi:10.1186/s12865-017-0229-5 · Cited by 9
Anti-inflammatory activity of small-molecule antagonists of Toll-like receptor 2 (TLR2) in mice
Wietzorrek, G., Drexel, M., Trieb, M., & Santos‐Sierra, S. (2018) · Immunobiology · doi:10.1016/j.imbio.2018.11.004 · Cited by 9
Juhás, Š., Harris, N., Il’ková, G., Rehák, P., Zsila, F., Kogan, F. Y., Lahmy, O., Zhuk, R. A., Gregor, P., & Koppel, J. (2017) · Inflammation · doi:10.1007/s10753-017-0688-0 · Cited by 9
Innate Priming of Neutrophils Potentiates Systemic Multiorgan Injury
Zhang, Y., Lin, R., Pradhan, K., Geng, S., & Li, L. (2020) · ImmunoHorizons · doi:10.4049/immunohorizons.2000039 · Cited by 8
SC2sepsis: sepsis single-cell whole gene expression database
Li, Y., Tan, R., Chen, Y., Liu, Z., Chen, E., Pan, T., & Qu, H. (2022) · Database · doi:10.1093/database/baac061 · Cited by 8
Venkataraman, R., Sprague, S., Ramakrishnan, N., Ramachandran, P., Jayakumar, D., Vijayaraghavan, B. K. T., Margabandhu, S., Ramanathan, Y. V., Adhikari, N. K. J., Lamontagne, F., et al. (2023) · Indian Journal of Critical Care Medicine · doi:10.5005/jp-journals-10071-24587 · Cited by 7
Liang, P., Wu, Y., Qu, S., Younis, M., Wang, W. J., Wu, Z., & Huang, X. (2024) · BMC Infectious Diseases · doi:10.1186/s12879-023-08883-9 · Cited by 8
Yin, S., Peng, Y., Lin, Y., Wu, H., Wang, B., Wang, X., Chen, W., Liu, T., Peng, H., Li, X., et al. (2024) · Microbiological Research · doi:10.1016/j.micres.2024.127626 · Cited by 8
Inflammaging in Multidrug-Resistant Sepsis of Geriatric ICU Patients and Healthcare Challenges
Kumar, N. R., Balraj, T. A., Shivashankar, K. K., Jayaram, T. C., & Prashant, A. (2024) · Geriatrics · doi:10.3390/geriatrics9020045 · Cited by 8
Inflammation and Autonomic Function
Amaro-Leal, Â., Carvalho, M., Rocha, I., & Mota‐Filipe, H. (2018) · InTech eBooks · doi:10.5772/intechopen.79280 · Cited by 9
Lessening Organ Dysfunction With Vitamin C (LOVIT) Trial: Statistical Analysis Plan
Adhikari, N. K. J., Pinto, R. L., Day, A. G., Masse, M.-H., Ménard, J., Sprague, S., Annane, D., Arabi, Y. M., Battista, M., Cohen, D., et al. (2022) · JMIR Research Protocols · doi:10.2196/36261 · Cited by 10
Fukuda, S., Niimi, Y., Hirasawa, Y., Manyeza, E. R., Garner, C. E., Southan, G. J., Salzman, A. L., Prough, D. S., & Enkhbaatar, P. (2021) · Scientific Reports · doi:10.1038/s41598-021-03320-w · Cited by 10
Smirnov, A., Pohlmann, S., Nehring, M., Ali, S., Mann‐Nüttel, R., Scheu, S., Antoni, A.-C., Hansen, W., Büettner, M., Gardiasch, M. J., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01622 · Cited by 8
The Emperor Has No Clothes? Searching for Dysregulation in Sepsis
Alcock, J. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm7090247 · Cited by 8
Ye, R., Wei, Y., Li, J., Xu, M., Xie, H., Huang, J., Deng, L., & Li, C. (2024) · Journal of Inflammation Research · doi:10.2147/jir.s492902 · Cited by 7
Melatonin Exerts Positive Effects on Sepsis Through Various Beneficial Mechanisms
Xu, J., Liang, C., Yao, S., & Wang, F. (2025) · Drug Design Development and Therapy · doi:10.2147/dddt.s509735 · Cited by 7
The progress of organ protection mechanisms in sepsis
Zhu, Y., Cheng, J., Sun, Z., Lu, J., & Li, M. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1729499 · Cited by 7
Christensen, E. E., Prebensen, C., Martinsen, A. B., Stiff, E. T., Hoff, R., Kvale, D., & Holten, A. R. (2023) · Critical Care Explorations · doi:10.1097/cce.0000000000000865 · Cited by 7
A machine-learning approach for prediction of hospital mortality in cancer-related sepsis
He, Y.-R., Liu, Y., Liu, Y., He, H., Liu, W., Huang, D., Gu, Z., & Ju, M. (2023) · Clinical eHealth · doi:10.1016/j.ceh.2023.06.003 · Cited by 7
Gray, C. C., Armstead, B. E., Chung, C., Chen, Y., & Ayala, A. (2023) · Journal of Leukocyte Biology · doi:10.1093/jleuko/qiad149 · Cited by 7
Key platelet genes play important roles in predicting the prognosis of sepsis
Shen, L., Tao, C., Zhu, K., Cai, L., Yang, S., Jin, J., Ren, Y., Xiao, Y., Zhang, Y., Lai, D., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-74052-w · Cited by 7
Gao, M., Zha, Y., Sheng, N., Cao, Y., Yao, W., Bao, B., Shan, M., Cheng, F., Yu, S., Zhang, Y., et al. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.136817 · Cited by 7
Transforming sepsis heterogeneity: challenges and progress
Dellinger, R. P., & Bartock, J. L. (2025) · Frontiers in Science · doi:10.3389/fsci.2025.1557323 · Cited by 7
Immunity check should be performed for all patients with septic shock? Yes
Textoris, J. (2020) · Intensive Care Medicine · doi:10.1007/s00134-019-05909-2 · Cited by 7
Hoffman, M., Kyriazis, I. D., Dimitriou, A., Mishra, S. K., Koch, W. J., & Drosatos, K. (2020) · JCI Insight · doi:10.1172/jci.insight.133675 · Cited by 7
Evaluation of the Wnt signaling pathway as a prognostic marker in patients with urosepsis
Shin, J., Yoon, Y., & Oh, D.-J. (2020) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-020-03804-9 · Cited by 7
Fish, M., Arkless, K. L., Jennings, A. R., Wilson, J., Carter, M. J., Arbane, G., Campos, S., Novellas, N. G., Wester, R., Petrov, N., et al. (2020) · Journal of the Intensive Care Society · doi:10.1177/1751143720966286 · Cited by 7
Harnessing the Versatility of Invariant NKT Cells in a Stepwise Approach to Sepsis Immunotherapy
Choi, J., Mele, T. S., Porcelli, S. A., Savage, P. B., & Haeryfar, S. M. M. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.2000220 · Cited by 7
Meegan, J. E., Komalavilas, P., Cheung‐Flynn, J., Yim, T. W., Putz, N. D., Jesse, J. J., Smith, K. D., Sidorova, T. N., Lee, H. N. R., Tomasek, T., et al. (2022) · Physiological Reports · doi:10.14814/phy2.15290 · Cited by 7
Yang, H., Cui, Y., Peng, W., Zhu, F., Ma, S., Rao, M., Zhang, P., Chen, J., & Pan, P. (2022) · Biomolecules · doi:10.3390/biom12101479 · Cited by 7
Zhang, M., Fergusson, D. A., Sharma, R., Khoo, C., Mendelson, A. A., McDonald, B., Macala, K. F., Sharma, N., Gill, S. E., Fiest, K. M., et al. (2023) · Systematic Reviews · doi:10.1186/s13643-023-02189-2 · Cited by 7
Laight, B. J., Jawa, N. A., Tyryshkin, K., Maslove, D. M., Boyd, J. G., & Greer, P. A. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1145826 · Cited by 7
Aging exacerbates cardiac dysfunction and mortality in sepsis through enhancing TLR2 activity
Zhai, Y., Yao, Q., The, E., Ao, L., Fullerton, D. A., & Meng, X. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1293866 · Cited by 7
The effect of IκK-16 on lipopolysaccharide-induced impaired monocytes
Galbraith, N. J., Manek, S. E., Walker, S., Bishop, C., Carter, J. V., Cahill, M. N., Gardner, S. A., Polk, H. C., & Galandiuk, S. (2017) · Immunobiology · doi:10.1016/j.imbio.2017.10.045 · Cited by 7
Björck, V., Påhlman, L. I., Törnebrant, J., & Bodelsson, M. (2018) · Scandinavian Journal of Trauma Resuscitation and Emergency Medicine · doi:10.1186/s13049-018-0530-1 · Cited by 7
Gu, Q., Huang, P., Yang, Q., Meng, X., & Zhao, M. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1433809 · Cited by 6
Fan, Y., Meng, S., Song, Y., Zhang, Y., Song, Y., Chen, Z., & Xie, K. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.114222 · Cited by 6
Im, P., Jeong, H., Kim, D., Song, J., Phan, N. M., Choi, E., Kim, Y., Jeong, S., Park, J., Park, I., et al. (2025) · Advanced Functional Materials · doi:10.1002/adfm.202415949 · Cited by 6
Jánosi, Á., Bódy, B., Nagy, R., Ocskay, K., Kói, T., Müller, K. E., Túri, I., Garami, M., Hegyi, P. J., & Párniczky, A. (2025) · Critical Care · doi:10.1186/s13054-025-05420-9 · Cited by 6
Insights Into a “Negative” ICU Trial Derived From Gene Expression Profiling
Hoekstra, M., Maslove, D. M., Veldhoen, R. A., Marshall, J. C., & Muscedere, J. (2019) · Critical Care Medicine · doi:10.1097/ccm.0000000000003693 · Cited by 6
Self-citationIκK-16 decreases miRNA-155 expression and attenuates the human monocyte inflammatory response
Galbraith, N. J., Burton, J. F., Ekman, M. B., Kenney, J., Walker, S., Manek, S. E., Bishop, C., Carter, J. V., Gardner, S. A., & Polk, H. C. (2017) · PLoS ONE · doi:10.1371/journal.pone.0183987 · Cited by 6
Schubert, B. D., Ku, H., Kabwe, M., Nguyen, T. H., Irving, H. R., & Tucci, J. (2022) · Viruses · doi:10.3390/v14112582 · Cited by 7
Risk Classification and Subphenotyping of Acute Kidney Injury: Concepts and Methodologies
Neyra, J. A., Chen, J., Bagshaw, S. M., & Koyner, J. L. (2022) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2022.10.011 · Cited by 6
Integrating biology into clinical trial design
van Amstel, R. B. E., van Vught, L. A., & Bos, L. D. J. (2022) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000001007 · Cited by 6
THE EUROPEAN SHOCK SOCIETY MEETS THE IMMUNOSEP CONSORTIUM FOR PERSONALIZED SEPSIS TREATMENT
Giamarellos‐Bourboulis, E. J., Dimοpoulos, G., Flohé, S. B., Kotsaki, A., van der Poll, T., Skirecki, T., Torres, A., & Netea, M. G. (2022) · Shock · doi:10.1097/shk.0000000000001955 · Cited by 6
Synergistic Aspects to Explain the Pathophysiology of Sepsis and Septic Shock-An Opinion
Koren, E., & Ginsburg (2015) · Journal of Infectious Diseases and Therapy · doi:10.4172/2332-0877.1000254 · Cited by 6
Looveren, K. V., & Libert, C. (2018) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2018.1539078 · Cited by 6
Sepsis endotypes: The early bird still gets the worm
Varon, J., & Baron, R. M. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.103832 · Cited by 6
Lee, C. M., Gupta, S., Parodo, J. C., Wu, J., Marshall, J. C., & Hu, J. (2015) · Genes and Immunity · doi:10.1038/gene.2015.10 · Cited by 6
Self-citationSepsis: neue Erkenntnisse, andere Perspektiven – neue Therapieoptionen?
Schlegel, N., Flemming, S., Meir, M., & Germer, C.-T. (2014) · Der Chirurg · doi:10.1007/s00104-014-2837-4 · Cited by 6
Metadata
- Authors
- Marshall, J. C.
- Affiliations
- St. Michael's Hospital (CA)
- Corresponding author
- Marshall, John C.
- ORCID
- Marshall, John C.
- Venue
- Trends in Molecular Medicine
- Publisher
- Elsevier BV
- Published
- 2014-04
- Volume
- 20
- Issue
- 4
- Pages
- 195-203
- ISSN
- 1471-4914 (ISSN-L)
- OpenAlex
- W1991209345
- Cited by
- 805
- References
- 56
- Citations by year
- 2026: 77 · 2025: 75 · 2024: 69 · 2023: 75 · 2022: 96 · 2021: 66 · 2020: 72 · 2019: 69 · 2018: 59 · 2017: 62 · 2016: 45 · 2015: 28 · 2014: 12
- FWCI
- 6.58
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Trends in Molecular Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Life Sciences › Immunology and Microbiology › Immunology › Inflammation biomarkers and pathways
- Health Sciences › Nursing › Nutrition and Dietetics › Vitamin C and Antioxidants Research
- Keywords
- sepsis, clinical trial failure, systemic inflammatory response, sepsis treatment, translational research, patient stratification, sepsis epidemiology, inflammatory markers
- MeSH terms
- Animals, Clinical Trials as Topic, Drug Evaluation, Preclinical, Humans, Immunity, Innate, Immunologic Factors, Treatment Outcome, Sepsis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review